These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27438467)

  • 21. Intraocular pressure-lowering effects of ripasudil, a rho-kinase inhibitor, and selective laser trabeculoplasty as adjuvant therapy in patients with uncontrolled glaucoma.
    Ono K; Sakemi F; Marumoto T
    Int Ophthalmol; 2021 Feb; 41(2):605-611. PubMed ID: 33079310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study.
    Tsukahara S; Enomoto N; Ishida K; Anraku A; Tomita G
    J Ocul Pharmacol Ther; 2020 Sep; 36(7):512-521. PubMed ID: 32412867
    [No Abstract]   [Full Text] [Related]  

  • 23. Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma.
    Inoue T; Tanihara H
    Expert Opin Pharmacother; 2017 Oct; 18(15):1669-1673. PubMed ID: 28893104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertension.
    Gandolfi SA; Lim J; Sanseau AC; Parra Restrepo JC; Hamacher T
    Adv Ther; 2014 Dec; 31(12):1213-27. PubMed ID: 25430900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a comparison with brimonidine.
    Chihara E; Dimitrova G; Chihara T
    Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1257-1264. PubMed ID: 29520478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ripasudil on diabetic macular edema.
    Minami Y; Song YS; Ishibazawa A; Omae T; Ro-Mase T; Ishiko S; Yoshida A
    Sci Rep; 2019 Mar; 9(1):3703. PubMed ID: 30842496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of ripasudil after trabeculectomy with mitomycin C: a multicentre, randomised, prospective clinical study.
    Muhlisah A; Hirooka K; Nurtania A; Onoe H; Okumichi H; Nitta E; Baba T; Tanito M; Matsuoka Y; Nakakura S; Kiuchi Y
    BMJ Open Ophthalmol; 2024 Jul; 9(1):. PubMed ID: 38960415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET).
    Araie M; Sugiyama K; Aso K; Kanemoto K; Iwata R; Hollander DA; Senchyna M; Kopczynski CC
    Adv Ther; 2023 Oct; 40(10):4639-4656. PubMed ID: 37603205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lowering of IOP by echothiophate iodide in pseudophakic eyes with glaucoma.
    Schmidt KG; Horowitz Y; Buckman G; Segev E; Levinger E; Geyer O
    Curr Eye Res; 2010 Aug; 35(8):698-702. PubMed ID: 20673046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.
    Ohta Y; Takaseki S; Yoshitomi T
    Jpn J Ophthalmol; 2017 Sep; 61(5):423-432. PubMed ID: 28653193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The intraocular pressure reducing effect of brinzolamide as adjunctive therapy to latanoprost.
    Li Yim JF; Montgomery DM
    Curr Med Res Opin; 2011 Aug; 27(8):1499-502. PubMed ID: 21651425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of ripasudil as an adjunct treatment in the management of pseudoexfoliative glaucoma.
    Mohapatra S; Thakur S; Panda BB; Das P
    Indian J Ophthalmol; 2023 Jul; 71(7):2756-2759. PubMed ID: 37417116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Ripasudil as a Second-line Medication in Addition to a Prostaglandin Analog in Patients with Exfoliation Glaucoma: A Pilot Study.
    Matsumura R; Inoue T; Matsumura A; Tanihara H
    Clin Drug Investig; 2017 Jun; 37(6):535-539. PubMed ID: 28349329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase 1 clinical trials of a selective Rho kinase inhibitor, K-115.
    Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Araie M;
    JAMA Ophthalmol; 2013 Oct; 131(10):1288-95. PubMed ID: 23787820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4.
    Terao E; Nakakura S; Fujisawa Y; Fujio Y; Matsuya K; Kobayashi Y; Tabuchi H; Yoneda T; Fukushima A; Kiuchi Y
    Curr Eye Res; 2017 May; 42(5):738-742. PubMed ID: 27911106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Outcomes and Prognostic Factors of Selective Laser Trabeculoplasty for Open-angle Glaucoma Receiving Maximal-tolerable Medical Therapy.
    Miki A; Kawashima R; Usui S; Matsushita K; Nishida K
    J Glaucoma; 2016 Oct; 25(10):785-789. PubMed ID: 26918911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ripasudil: first global approval.
    Garnock-Jones KP
    Drugs; 2014 Dec; 74(18):2211-5. PubMed ID: 25414122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral administration of forskolin and rutin contributes to intraocular pressure control in primary open angle glaucoma patients under maximum tolerated medical therapy.
    Vetrugno M; Uva MG; Russo V; Iester M; Ciancaglini M; Brusini P; Centofanti M; Rossetti LM
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):536-41. PubMed ID: 22731245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Bimatoprost Plus Timolol Fixed Combination in Open Angle Glaucoma Patients Previously Treated with Dorzolamide Plus Timolol Fixed Combination.
    Sacchi M; Specchia C; Williams SE; Villani E; Nucci P
    Curr Eye Res; 2016 Nov; 41(11):1433-1437. PubMed ID: 27115319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Ocular Pulse Amplitude-Lowering Effects of Tafluprost and Latanoprost by Dynamic Contour Tonometry.
    Park SH; Yoo SH; Ha SJ
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):617-22. PubMed ID: 26348718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.